Published in Hepatology on January 01, 2000
In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol (2001) 1.54
Trolox and ascorbic acid reduce direct and indirect oxidative stress in the IPEC-J2 cells, an in vitro model for the porcine gastrointestinal tract. PLoS One (2015) 1.42
HO-1-STAT3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling. J Hepatol (2011) 1.19
N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway. PLoS One (2014) 1.03
Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury. Mol Ther (2009) 0.92
Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). PLoS One (2014) 0.92
The influence of oxygen tension on the structure and function of isolated liver sinusoidal endothelial cells. Comp Hepatol (2008) 0.87
Inflammatory cytokines induce MAdCAM-1 in murine hepatic endothelial cells and mediate alpha-4 beta-7 integrin dependent lymphocyte endothelial adhesion in vitro. BMC Physiol (2007) 0.83
Renoprotective approaches and strategies in acute kidney injury. Pharmacol Ther (2016) 0.82
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest (2000) 3.17
Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis (2001) 2.63
Hepatitis C virus in intravenous drug users. Med J Aust (1990) 2.33
Androgen-induced hepatoma. Lancet (1975) 2.21
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 2.19
The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust (1994) 2.15
Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology (1996) 1.83
Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Which patients with hepatitis C develop liver complications? Hepatology (2000) 1.73
Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology (1995) 1.41
Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem (1997) 1.40
Confusion, cortical blindness and fever. Med J Aust (1995) 1.38
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol (2000) 1.19
Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology (1995) 1.18
Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther (1979) 1.13
Drug-induced cholestasis. Semin Gastrointest Dis (2001) 1.13
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice. Br J Cancer (2012) 1.10
Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab (1998) 1.07
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatment. J Gastroenterol Hepatol (1998) 1.06
Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun (1999) 1.06
Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat (1995) 1.01
Does hepatitis C virus play a role in "non-viral" chronic liver disease? Med J Aust (1990) 1.01
Inhibition of theophylline metabolism by interferon. Lancet (1987) 1.01
Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology (1978) 1.01
Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo. J Biol Chem (1979) 0.99
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat (2008) 0.98
Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J (2004) 0.95
Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis. Biochem Pharmacol (1995) 0.95
Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol (1999) 0.92
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol (1998) 0.91
Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury. J Hepatol (2001) 0.91
Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol (1995) 0.91
Influence of clinicopathological variables on CYP protein expression in human liver. J Gastroenterol Hepatol (1996) 0.89
Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology (1996) 0.89
Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme. J Biol Chem (1980) 0.89
Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes. Med J Aust (1994) 0.88
Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med J Aust (1992) 0.88
Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylation. J Biol Chem (1981) 0.87
Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem Pharmacol (1986) 0.87
Interferon suppresses erythromycin metabolism in rats and human subjects. Hepatology (1993) 0.87
Accuracy and clinical utility of simplified tests of antipyrine metabolism. Br J Clin Pharmacol (1984) 0.86
The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture. In Vitro Cell Dev Biol Anim (1999) 0.86
The central role of sinusoidal endothelial cells in hepatic hypoxia-reoxygenation injury in the rat. Hepatology (1996) 0.86
Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis. Hepatology (1995) 0.84
Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem Biophys Res Commun (2000) 0.84
Hepatitis B in Australia: determinants of intrafamily spread. Aust N Z J Med (1987) 0.84
Exogenous heme restores in vivo functional capacity of hepatic cytochrome P-450 destroyed by allylisopropylacetamide. Biochem Biophys Res Commun (1979) 0.84
How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? J Gastroenterol Hepatol (1998) 0.84
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol (1996) 0.83
Effects of portal vein ligation on sex hormone metabolism in male rats: relationship to lowered hepatic cytochrome P450 levels. Gastroenterology (1986) 0.83
Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol Pharmacol (1990) 0.83
Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J Viral Hepat (1996) 0.83
Chronic ethanol administration to rats decreases receptor-operated mobilization of intracellular ionic calcium in cultured hepatocytes and inhibits 1,4,5-inositol trisphosphate production: relevance to impaired liver regeneration. J Clin Invest (1996) 0.82
Non-alcoholic steatohepatitis: impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol (1992) 0.82
Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-gamma1: relevance to impaired hepatocyte proliferation. Biochem Biophys Res Commun (1999) 0.82
Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450. J Pharmacol Exp Ther (1981) 0.82
Molecular epidemiology of hepatitis C in Australia. J Gastroenterol Hepatol (1998) 0.82
Inhibition of antipyrine metabolism by interferon. Br J Clin Pharmacol (1986) 0.82
Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C. Hum Pathol (1998) 0.81
Efflux of bilirubin into plasma following hepatic degradation of exogenous heme. Proc Soc Exp Biol Med (1980) 0.81
Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastroenterol Hepatol (1996) 0.81
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust N Z J Med (1991) 0.81
Portal vein ligation selectively lowers hepatic cytochrome P450 levels in rats. Gastroenterology (1983) 0.80
Current approaches to the diagnosis and management of hepatocellular carcinoma. Clin Exp Med (2005) 0.80
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice. Int J Obes (Lond) (2011) 0.80
Impaired bile flow and disordered hepatic calcium homeostasis are early features of halothane-induced liver injury in guinea pigs. Hepatology (1996) 0.80
Microsomal protein synthesis and induction of cytochrome P-450 in cirrhotic rat liver. Aust J Exp Biol Med Sci (1984) 0.80
Impaired androgen 16 alpha-hydroxylation in hepatic microsomes from carbon tetrachloride-cirrhotic male rats. Gastroenterology (1987) 0.79
Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology (1998) 0.79
Time-dependent expression of cytochrome P450 genes in primary cultures of well-differentiated human hepatocytes. J Lab Clin Med (1997) 0.79
Increased binding of benzo[a]pyrene metabolites to lymphocytes from patients with lung cancer. Cancer Lett (1986) 0.79
Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology (1987) 0.79
Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450. Arch Biochem Biophys (1986) 0.79
Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide. J Pharmacol Exp Ther (1993) 0.79
Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity. Hepatology (1989) 0.78
The hepatic side-effects of drugs. Med J Aust (1987) 0.78
Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease. Eur J Clin Pharmacol (1979) 0.78
Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone. Biochem Biophys Res Commun (1998) 0.78
Hepatitis C: an economic evaluation of extended treatment with interferon. Med J Aust (1999) 0.78
Pretranslational down-regulation of male specific hepatic P450s after portal bypass. Biochem Pharmacol (1994) 0.78
Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat. Gastroenterology (1989) 0.78
Effects of extracellular Ca2+ and HCO3- on epidermal growth factor-induced DNA synthesis in cultured rat hepatocytes. Gastroenterology (1995) 0.78
Halothane-induced liver injury in guinea-pigs: importance of cytochrome P450 enzyme activity and hepatic blood flow. J Gastroenterol Hepatol (1996) 0.78
Fanconi's familial hypoplastic anaemia with some unusual features. Med J Aust (1976) 0.78
Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Aust N Z J Med (1990) 0.78
Hepatic heme metabolism and cytochrome P450 in cirrhotic rat liver. Gastroenterology (1985) 0.77
Crigler-Najjar Type 1 syndrome: absence of hepatic bilirubin UDP-glucuronyl transferase activity and therapeutic responses to light. Aust N Z J Med (1982) 0.77
Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats. Hepatology (1993) 0.77
Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Gastroenterology (1995) 0.77
Abnormal liver function in chronic hypervitaminosis A. Am J Dig Dis (1977) 0.77
Cerebrospinal fluid gamma-aminobutyric acid levels in dogs with chronic portosystemic encephalopathy. Clin Sci (Lond) (1986) 0.77
Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study. Aust N Z J Med (1999) 0.77
Culture and transfection of mammalian primary hepatocytes and hepatocyte-derived cell lines. J Gastroenterol Hepatol (1998) 0.77
Hepatic microsomal metabolism of androst-4-ene-3,17-dione: relative importance of ring hydroxylation and aromatization in control and induced rat liver. J Steroid Biochem (1988) 0.76